JACK E. RIGGS, M.D.; ROBERT C. GRIGGS, M.D., F.A.C.P.; RICHARD T. MOXLEY III, M.D.
Acetazolamide has been shown to be effective prophylaxis for both hypokalemic and hyperkalemic periodic paralysis. A patient with paramyotonia congenita, a related disorder with myotonia and episodic weakness, was studied during treatment with acetazolamide. Although the patient's myotonia was virtually abolished, severe quadriparesis was produced during each trial of acetazolamide. This response distinguished this patient's condition from other forms of familial periodic paralysis and suggests that acetazolamide may be deleterious to some patients with periodic paralysis.
Learn more about subscription options.
Register Now for a free account.
RIGGS JE, GRIGGS RC, MOXLEY RT. Acetazolamide-Induced Weakness in Paramyotonia Congenita. Ann Intern Med. 1977;86:169–173. doi: 10.7326/0003-4819-86-2-169
Download citation file:
Published: Ann Intern Med. 1977;86(2):169-173.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only